Advertisement

Organisation › Details
Eli Lilly & Co. Inc. (NYSE: LLY)
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. *
![]() |
Start | 1990-01-01 existent |
Group | Eli Lilly (Group) | |
![]() |
Industry | pharmaceutical |
![]() |
Region | Indianapolis, IN |
Country | United States (USA) | |
Street | Lilly Corporate Center | |
City | 46285 Indianapolis, IN | |
Tel | +1-317-276-2000 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | H: 10,001 to 50,00 (2022-12-31) |
Currency | USD | |
Annual sales | 28,541,400,000 (sales, net, consolidated (2022) 2022-12-31) | |
Profit | 6,244,800,000 (2022-12-31) | |
Cash | 2,067,000,000 (2022-12-31) | |
* Document for »About Section«: | ||
Record changed: 2025-01-12 |
Advertisement

More documents for Eli Lilly (Group)
- [1] NanoSyrinx Ltd.. (9/10/24). "Press Release: NanoSyrinx Closes £10 Million GBP Financing and Appoints Dr. Edwin Moses as Chairman". Coventry....
- [2] Qiagen N.V.. (9/4/24). "Press Release: Qiagen and Lilly Collaborate to Support Development of a QIAstat-Dx IVD Panel that Identifies Patients at Risk for Developing Alzheimer’s disease". Venlo....
- [3] Haya Therapeutics SA. (9/4/24). "Press Release: Haya Therapeutics Announces Collaboration with Lilly to Discover Novel Regulatory Genome Targets for Obesity and Related Metabolic Conditions Using Proprietary RNA Platform". Lausanne & San Diego, CA....
- [4] Kurma Partners. (5/2/24). "Press Release: Kurma Partners Announces the Promotion of Hadrien Bouchez to the Position of Partner". Paris....
- [5] Eli Lilly and Company. (12/27/23). "Press Release: Lilly Completes Acquisition of Point Biopharma". Indianapolis, IN....
- [6] Eli Lilly and Company. (11/17/23). "Press Release: Lilly to Expand Injectable Manufacturing Capacity with Planned $2.5 Billion Site in Germany". Indianapolis, IN....
- [7] Eli Lilly and Company. (11/17/23). "Press Release: Lilly Extends Tender Offer to Acquire Point Biopharma to Dec. 1, 2023". Indianapolis, IN....
- [8] Mablink Bioscience SAS. (10/18/23). "Press Release: Mablink Bioscience Enters an Agreement to be Acquired by Lilly". Lyon....
- [9] Eli Lilly and Company. (10/3/23). "Press Release: Lilly to Acquire Point Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies". Indianapolis, IN....
- [10] Eckert & Ziegler AG. (9/25/23). "Press Release: Eckert & Ziegler Signs Strategically Important Agreement for the Supply of Lutetium-177 with POINT Biopharma". Berlin....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top